Clinical Trial: Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: Treatment of DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) With Tegeline®

Brief Summary: Efficacy and tolerance of Tegeline® treatment in hypersensitivity syndrome. Immunological study of the T cell index phenotype and functionality in hypersensitivity syndrome.

Detailed Summary:
Sponsor: University Hospital, Rouen

Current Primary Outcome: express healing of visceral attacks, healing of polyadenopathy and body temperature, biological abnormal values normalisation, express healing of cutaneous and mucous diseases immunological study of the T cell index phenotype [ Time Frame: 1 year ]

Original Primary Outcome: express healing of visceral attacks healing of polyadenopathy and body temperature biological abnormal values normalisation express healing of cutanéous and mucous diseases immunological study of the T cell index phenotype [ Time Frame: 1 year ]

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University Hospital, Rouen

Dates:
Date Received: July 20, 2007
Date Started: January 2008
Date Completion:
Last Updated: March 23, 2015
Last Verified: March 2015